19.56
+1.19(+6.48%)
Currency In USD
| Previous Close | 18.37 |
| Open | 18.48 |
| Day High | 20.01 |
| Day Low | 18.47 |
| 52-Week High | 61.07 |
| 52-Week Low | 13.7 |
| Volume | 531,898 |
| Average Volume | 507,643 |
| Market Cap | 366.09M |
| PE | -7.27 |
| EPS | -2.69 |
| Moving Average 50 Days | 18.65 |
| Moving Average 200 Days | 19.94 |
| Change | 1.19 |
Tectonic Therapeutic to Participate in December Investor Conferences
GlobeNewswire Inc.
Dec 01, 2025 1:00 PM GMT
WATERTOWN, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the act
Tectonic Therapeutic Announces Positive Topline Data from Phase 1b Part B Clinical Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFrEF
GlobeNewswire Inc.
Oct 29, 2025 8:01 PM GMT
TX45 improved both left heart function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with reduced Ejection Fraction (“PH‑HFrEF”)TX45 was well tolerated in patients with PH‑HFrEF with no serious or severe
Tectonic Therapeutic to Participate in September Investor Conferences
GlobeNewswire Inc.
Aug 28, 2025 1:00 PM GMT
WATERTOWN, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the act